Sfoglia per Autore
A meta-analysis of 22108 patients undergoing PCI: can radial approach reduce the incidence of acute kidney injury?
2015-01-01 Ando', Giuseppe; Costa, Francesco; Boretti, Ilaria; Trio, Olimpia; Valgimigli, M.
Impact of a 24- rather than 6-month dual antiplatelet therapy with clopidogrel in patients with left main or proximal left anterior descending coronary artery disease. A post hoc analysis from the (Prolonging Dual Antiplatelet Treatment After Grading Stent Induced Intimal Hyperplasia) PRODIGY trial
2015-01-01 Costa, Francesco; Ariotti, S.; Oreto, Giuseppe; Ando', Giuseppe; Valgimigli, M.
Exploring the Incremental Value of CRUSADE Score as Clinical Guidance for the Decision-Making of Dual Antiplatelet Therapy Duration: A Retrospective Analysis from the (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) PRODIGY Trial Pathway
2015-01-01 Costa, Francesco; Peter, Damman; Pascal, Vranckx; Sergio, Leonardi; Elisabetta, Moscarella; Ando', Giuseppe; Paolo, Calabrò; Oreto, Giuseppe; Felix, Zijlstra; Marco, Valgimigli
Long-term use of ticagrelor in patients with prior myocardial infarction [2]
2015-01-01 Costa, Francesco; Valgimigli, Marco
Impact of greater than 12-month dual antiplatelet therapy duration on mortality: Drug-specific or a class-effect? A meta-analysis
2015-01-01 Costa, Francesco
Bleeding risk stratification in acute coronary syndromes. Is it still valid in the era of the radial approach?
2015-01-01 Andó, Giuseppe; Costa, Francesco
Does smoking habit affect the randomized comparison of 6 versus 24-month dual antiplatelet therapy duration? Insights from the PRODIGY trial
2015-01-01 Adamo, Marianna; Costa, Francesco; Vranckx, Pascal; Leonardi, Sergio; P Navarese, Eliano; M Garcia-Garcia, Hector; Valgimigli, Marco
Perspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization: Fifty Years of Revascularization: Where Are We and Where Are We Heading?
2015-01-01 Costa, Francesco; Ariotti, Sara; Valgimigli, Marco; Kolh, Philippe; Windecker, Stephan
Anatomic Characteristics and Clinical Implications of Angiographic Coronary Thrombus
2015-01-01 M Campos, Carlos; Costa, Francesco; M Garcia-Garcia, Hector; Bourantas, Christos; Suwannasom, Pannipa; Valgimigli, Marco; Morel, Marie-Angele; Windecker, Stephan; W Serruys, Patrick
Impact of Clinical Presentation on Ischemic and Bleeding Outcomes in Patients Receiving 6 or 24 Month Duration of Dual Antiplatelet Therapy After Stent Implantation: A Pre-Specified Analysis from the (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) PRODIGY Trial
2015-01-01 Costa, Francesco; Pascal, Vranckx; Sergio, Leonardi; Elisabetta, Moscarella; Ando', Giuseppe; Paolo, Calabrò; Oreto, Giuseppe; Felix, Zijlstra; Marco, Valgimigli
Coronary stent selection and optimal course of dual antiplatelet therapy in patients at high bleeding or thrombotic risk: Navigating between limited evidence and clinical concerns
2015-01-01 Ariotti, Sara; Costa, Francesco; Valgimigli, Marco
Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial
2015-01-01 Crimi, Gabriele; Leonardi, Sergio; Costa, Francesco; Ariotti, Sara; Tebaldi, Matteo; Biscaglia, Simone; Valgimigli, Marco
Incremental Value of the CRUSADE, ACUITY, and HAS-BLED Risk Scores for the Prediction of Hemorrhagic Events After Coronary Stent Implantation in Patients Undergoing Long or Short Duration of Dual Antiplatelet Therapy
2015-01-01 Costa, Francesco; Tijssen, Jan G; Ariotti, Sara; Giatti, Sara; Moscarella, Elisabetta; Guastaroba, Paolo; De Palma, Rossana; Ando', Giuseppe; Oreto, Giuseppe; Zijlstra, Felix; Valgimigli, Marco
Duration of dual antiplatelet therapy after drug-eluting stent implantation: Will we ever reach a consensus?
2015-01-01 Valgimigli, Marco; Ariotti, Sara; Costa, Francesco
Impact of Clinical Presentation on Dual Antiplatelet Therapy Duration Let's Re-Evaluate Our Priorities
2015-01-01 Costa, F; Valgimigli, M
Dual antiplatelet therapy duration after coronary stenting in clinical practice: Results of an EAPCI survey
2015-01-01 Valgimigli, Marco; Costa, Francesco; Byrne, Robert; Haude, Michael; Baumbach, Andreas; Windecker, Stephan
Benefit of radial approach in reducing the incidence of acute kidney injury after percutaneous coronary intervention: A meta-analysis of 22,108 patients
2015-01-01 Giuseppe Andò;Francesco Costa;Ilaria Boretti;Olimpia Trio;Marco Valgimigli
Transesophageal contrast echocardiography is not always the gold standard method in the identification of a patent foramen ovale: A clinical case
2015-01-01 Lunetta, Monica; Costa, Francesco; La Gattuta, Marcello; Novo, Salvatore
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: Meta-analysis of randomised controlled trials
2015-01-01 Pio Navarese, Eliano; Andreotti, Felicita; Schulze, Volker; Kołodziejczak, Michalina; Buffon, Antonino; Brouwer, Marc; Costa, Francesco; Kowalewski, Mariusz; Parati, Gianfranco; H Lip, Gregory Y; Kelm, Malte; Valgimigli, Marco
Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial
2015-01-01 Costa, Francesco; Vranckx, P; Leonardi, S; Moscarella, E; Ando', Giuseppe; Calabro, P; Oreto, Giuseppe; Zijlstra, F; Valgimigli, M.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile